Eaton Vance Management Jazz Pharmaceuticals PLC Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Eaton Vance Management holds 23,862 shares of JAZZ stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,862
Previous 23,413
1.92%
Holding current value
$2.54 Million
Previous $3.65 Million
12.95%
% of portfolio
0.0%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding JAZZ
# of Institutions
514Shares Held
57.1MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$753 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$687 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$262 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$253 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$159 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.67B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...